A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease models.
Ganz J, Shacham T, Kramer M, Shenkman M, Eiger H, Weinberg N, Iancovici O, Roy S, Simhaev L, Da'adoosh B, Engel H, Perets N, Barhum Y, Portnoy M, Offen D, Lederkremer GZ.
Ganz J, et al. Among authors: portnoy m.
Sci Rep. 2020 Apr 23;10(1):6875. doi: 10.1038/s41598-020-63899-4.
Sci Rep. 2020.
PMID: 32327686
Free PMC article.